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Abstract 
Introduction: Diabetic dyslipidemia is regarded as risk factor for development of cardiovascular disease and it is 
the primary cause of morbidity and mortality in diabetes. LDL- cholesterol is primarily used as the marker of CVD 
risk while other markers like lipid ratios, AIP and atherogenic coefficient are the better markers for the prediction of 
CVD. Objective: The present study was aimed to evaluate the non-HDL cholesterol, AIP and other cardiac indices 
as CVD risk in diabetic patients. Material & Methods: This cross-sectional study was carried out in the 
Department of Biochemistry and Department of Medicine Muzaffarnagar Medical College, Muzaffarnagar. Total 
240 patients were enrolled for this study, out of which 120 were diabetic and 120 were normal healthy control of 
both the sexes. Anthropometric parameters like age, weight, height, blood pressure and the biochemical parameters 
including fasting blood sugar, lipid parameters, cardiac risk ratio, atherogenic index of plasma, atherogenic 
coefficient and non-HDL cholesterol were measured. For statistical analysis SPSS version 16 was used and for 
significance, p-value less than 0.05 was considered. Results: In this study, the fasting blood glucose, HbA1c, Total 
cholesterol, triglycerides, LDL-cholesterol were found to be increased significantly and HDL- cholesterol was found 
to be decreased significantly in Diabetic patients as compared to normal healthy control. The cardiac indices like, 
Cardiac Risk ratio (CRR), atherogenic Index of plasma (AIP), atherogenic coefficient (AC) and non-HDL 
cholesterol were also found to be increased significantly in diabetic patients as compared to normal healthy 
individuals. Conclusion: The present study concluded that the lipid ratios are more convenient clinically and they 
can be useful in assessing the cardiovascular complications in diabetic patients instead of lipid profile alone. 
Keywords: Non-HDL Cholesterol, Atherogenic Coefficient, Cardiac Risk Ratio, Dyslipidemia. 
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terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative 
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Introduction 
 
Diabetes mellitus (DM) is  one of the major global  
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disorder; characterized by long standing hyperglycemia 
due to absolute or relative deficiency of insulin 
secretion or its action.[1] The dyslipidemia presents a 
major [probably the most important] link between 
diabetes and cardiovascular disease. Diabetic dys-
lipidemia has been the main focus of discussions 
regarding the interaction between glucose and lipid 
metabolism.[2] The risk of CV mortality in patients 
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with type 2 diabetes (T2DM) is 2-4 times that observed 
in individuals without diabetes.[3]Indian people are 
genetically predisposed to the development of 
cardiovascular disease due to dyslipidemia and 
decreased levels of high density lipoproteins.[4] Many 
researchers found that the non-high density lipoprotein 
cholesterol (non-HDL-C) may be more powerful 
biomarker for prediction of cardiovascular disease  as  
compared to low density lipoprotein-cholesterol alone.  
[5, 6] This indicates that many diabetic patients fail to 
reach goals for non-HDL-C. They meet their target 
LDL cholesterol goal but still develop complications 
from atherosclerotic vascular disease and suffer from 
cardiovascular events. Non-HDL cholesterol is 
identified as the corrective target at that level of TG. 
Non-HDL cholesterol may be considered as a marker 
for predicting CVD and it is calculated by subtracting 
HDL cholesterol from total cholesterol. The calculating 
non-HDL-C and other lipid ratios could be more 
effective than all lipoproteins. [6]Lipid ratios have also 
been found to indicate an atherogenic risk and are said 
to better predictors of cardiovascular diseases than 
lipids alone. Instead of lipid parameters, increased 
lipoprotein ratios have a better statistical association 
with severity and prevalence of Coronary Artery 
Disease (CAD) [7]. Many factors account for increased 
cardiovascular disease risk in diabetes but lipid 
abnormalities are major contributors. It is well known 
that people with diabetes have increased cardiovascular 
risk. Early assessment and control of CV risk factors in 
patients with T2DM has a positive effect on reducing 
the risk of CVD and death in patients and improving 
the prognosis of patients.Now days, researchers have 
focused on a new lipid index, the atherogenic index of 
plasma (AIP), which might comprehensively reflect the 
balance between atherogenic and anti-atherogenic 
factors. many researchers in their study showed that 
AIP, a better marker for predicting the risk of CAD.[8-
10] A study conducted in Iran, showed a positive 
association between AIP , waist circumference and 
body mass index and negative association with 
physical activity.[8]  Ath-erogenic index of plasma 
(AIP) is calculated as log (TG/HDL-C) and it has been 
designated as a predictor of atherosclerosis and 
surrogate of small low-density lipoprotein particle 
size.[11, 12]. Hence the present study was aimed to 
assess the Atherogenic coefficient and Atherogenic 
index of plasma and other cardiac indices in assessing 
Cardiovascular risk in Diabetic patients. These all are 
calculated fractions which may be used in the clinical 
laboratory for assessing the risk of cardiovascular 
disease beyond the routinely done lipid profile. 
 
Materials and Methods 
 
This study was carried out in the Department of 
Biochemistry and Outpatient Department of Medicine 
Muzaffarnagar Medical College, Muzaffarnagar from 
February 2019 to August 2019. The cases were 
selected from those who attended the Medicine 
Outpatient Department at Muzaffarnagar Medical 
College and Hospital, Muzaffarnagar. The sample size 
was calculated by using the prevalence rate of Diabetes 
Mellitus in Western UP (8.03%),[13] so the sample 
size of the study was around 113.48. Permission from 
the ethical committee and informed consent were taken 
from every subject. All the investigations were done in 
the Biochemistry Department, Muzaffarnagar Medical 
College and Hospital, Muzaffarnagar.  
Inclusion Criteria 
A total of 240 subjects of both sex groups were 
enrolled for this study. Out of which 120 were Diabetic 
(As per IDF criteria) and 120 were normal healthy non-
diabetic individuals which was serve as controls for 
this study. 
Exclusion Criteria  
The subjects with hepatic disease, cardiovascular 
disease, any chronic or acute inflammatory illness, all 
types of cancer, pulmonary tuberculosis, addiction to 
alcohol, who smoke and having prolonged illness were 
excluded from the study.  
Collection of Blood Sample  
About 5 ml of blood was drawn after an overnight fast 
under aseptic precautions from clinically diagnosed 
type 2 DM patients and controls. Fasting plasma 
glucose level and lipid parameters were done by 
enzymatic method by using automated analyzer. 
Cardiac Risk ratio, Atherogenic Index of Plasma, non-
HDL cholesterol and Atherogenic Coefficient were 
calculated as follows: 
1. CRR (Cardiac Risk Ratio) = Total Cholesterol / 
HDL-Cholesterol 
2. AC (Atherogenic Coefficient) = (Total Cholesterol-
HDL cholesterol) / HDL-cholesterol 
3. AIP  = Log Triglyceride / HDL-cholesterol (mmol/l) 
4. Non-HDL-cholesterol = Total Cholesterol – HDL-
cholesterol 
Statistical Analysis  
SPSS version-16 was used for Statistical analysis and a 
p<0.05 was considered as statistically significant. The 
statistical differences between the groups were 
determined by student independent sample t-test. 
 
Results 
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240 patients were enrolled for this study; out of which 
120 were diabetic and 120 normal healthy individuals 
of both the sex. Table 1 represents the demographic 
parameters in diabetic and normal healthy individuals. 
The mean values of weight, BMI, systolic and diastolic 
blood pressure were increased significantly in diabetic 
patients as compared to controls. 
The table 2 represents the biochemical parameters of 
normal and diabetic patients. The mean value of FBS, 
HbA1c, TC, TG, LDL-cholesterol, Non HDL-
cholesterol, CRR, AC and AIP were found to be 
increased significantly in diabetic patients as compared 
to normal healthy individuals.  
 
 
Table 1: Showing Demographic parameters in diabetic and normal healthy individual 
 
S.No. Variables Diabetics Healthy Controls p-Value 
1 Age (years) 38.72 ± 9.50 37.17 ± 10.12 0.22 NS 
2 Weight (Kg) 59.27 ± 4.16 76.17 ± 8.19 <0.001S 
3 Height (Meter) 1.59 ± 0.033 1.67 ± 0.046 <0.001S 
4 BMI (Kg/Meter2) 23.38 ± 1.38 27.39 ± 3.21 <0.001S 
5 Systolic Blood pressure (mm of Hg) 119.47 ± 7.33 129.57 ± 8.56 <0.001S 
6 Diastolic Blood Pressure (mm of Hg) 78.58 ± 3.38 84.30 ± 4.28 <0.001S 
 
Table 2: Showing biochemical parameters and cardiac indices in diabetic and normal healthy individual 
 
S.No. Variables Diabetics Healthy Controls p-Value 
1 Fasting Blood Glucose (mg/dL) 177.74 ± 21.35 96.66 ± 8.53 <0.001 
2 HbA1c 8.28 ± 1.7 5.16 ± 0.62  <0.001 
3 Total Cholesterol 240.08 ± 22.58  174.00 ±16.65 <0.001 
12 Triglyceride (mmol/L) 2.29 ±0.165 1.55 ± 0.11 <0.001 
13 HDL-cholesterol (mmol/L) 1.02 ± 0.11 1.14 ± 0.14 <0.001 
6 LDL-cholesterol (mg/dL) 159.86 ± 22.20 100.65 ± 24.15 <0.001 
7 VLDL-cholesterol 40.62 ± 2.93 27.45 ± 2.00 <0.001 
8 Non-HDL-cholesterol (mg/dL) 200.48 ± 22.83 129.77 ± 21.53 <0.001 
9 Cardiac Risk Ratio 5.13 ± 0.86 3.03 ± 0.83 <0.001 
10 Atherogenic Index of Plasma 0.71 ± 0.071 0.134± 0.063 <0.001 
11 Atherogenic Coefficient 6.13 ± 0.86 4.03  ± 0.83 <0.001 
 
Discussion 
 
The prevalence of diabetes mellitus increases 
continuously and become one of the common  
prevalent diseases. A strong association was found 
between diabetes and cardiovascular disease, which is 
the most cause of morbidity and mortality in diabetic 
patients. Cardiovascular risk factors such as 
hypertension, obesity, dyslipidemia are common in 
diabetic patients and enhances the risk for cardiac 
events. [14]   A researcher in their study reported that 
the incidence of CVD in diabetic patients was three 
times more and it has become the major risk factor for 
diabetic associated morbidity and mortality.[15] 
In the present study, the AIP is found to be increased in 
diabetic patients as compared to healthy individual and 
it was statistically significant. Our results are in 
accordance with the many researchers. [16-19] AIP is a 
simple relationship between TG and HDL cholesterol 
and can be considered as good predictor of 
atherosclerosis [20]. The cardiac risk ratio and 
atherogenic coefficient were found to be increased 
significantly in diabetic patients as compared to normal 
healthy individual. Our results are in agreement with 
many researchers.[21, 22]. Risk factors for more 
aggregation in patients with T2DM include insulin 
resistance, central obesity, elevated blood pressure, and 
elevated triglycerides. It may be due to increased 
oxidative stress, increased inflammation, or endothelial 
cell dysfunction in association with low HDL 
cholesterol. [23] The risk factors associated with 
increased AIP are closely related to those for CVD and 
cerebrovascular disease in patients with Diabetes.In the 
present study we have observed significant increased 
level of non HDL cholesterol in diabetic patient as 
compared to normal healthy individual. Many 
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researchers were obtained same results. [24-26]  Many 
Studies have shown that the non-HDL-c being 
analogous to Apo-B in assessing atherogenic 
cholesterol and lipoprotein burden.[27] Although apo B 
can be measured directly but the measurement of non 
HDL cholesterol is more practical, reliable and 
inexpensive and is accepted as a surrogate marker for 
apoB in routine clinical practice [28].In diabetic 
patients it may be Insulin deficiency that causes 
increased metabolization of free fatty acid that may 
lead to disorder in lipid metabolism and stimulates 
protein kinase-C pathway. All these impair the 
vasodilatory response and hence predict the 
cardiovascular disease. The increase in triacylglycerol 
level may be due to the accumulation of triacyl-
glycerol, increased lipogenesis and decreased fatty acid 
oxidation. Insulin resistance causes more catabolism of 
HDL particles and formation of LDL particles, this 
may lead to increase in LDL and decrease in HDL 
levels in type 2 diabetes. [29] Lipid ratios and AIP 
have been reported to indicate atherogenic 
dyslipidemia. Various lipid and lipoprotein fractions 
were shown to be associated in diabetes with and 
without complications. Researchers in their study 
observed that the atherogenic index and TC/HDL-c 
levels were significantly higher in diabetic patients 
than in controls and both these were found to be 
lowered in patients on treatment with insulin.[30] 
These findings suggest the role of lipid ratios in 
identifying the CV risk rather than the individual lipids 
alone. 
Conclusion 
 
In Diabetes, the alteration in the utilization of lipids 
and lipoproteins takes place that may induce 
atherogenic dyslipidemia and it is one of the most 
common risk factor for the development of 
atherosclerosis. Primarily, Low density lipoprotein 
cholesterol is used as the marker of cardiovascular risk 
in diabetes. Lipid ratios, atherogenic coefficient and 
atherogenic index of plasma have been found to 
indicate an atherogenic risk and are better predictors of 
cardiovascular risk than lipids alone. Hence all these 
parameters can be included in routine cardiac profile as 
the predictor of atherosclerotic damage. 
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